Feature | March 31, 2014

ACC, AHA, SCAI Publish Structured Reporting Initiative to Standardize and Improve Patient Care

New health policy statement supports efforts to improve effectiveness, communication and coordination

March 31, 2014 — Led by members of the American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), 14 professional societies from across the world have developed a health policy statement that defines the clinical standards for structured reporting in the cardiac catheterization suite. The statement was published online last week in the Journal of the American College of Cardiology and Circulation.

The goal of structured reporting is to produce clear, concise, thorough and organized reports on catheterization procedures that include all information relevant to both clinical care and operational administration. For instance, it should include a minimum dataset that anticipates clinical, operational, regulatory and financial uses, and documents indications and appropriateness.

The result of this approach should be data-intensive reports that concisely and efficiently convey the details of a variety of catheterization procedures, such as those involving the heart and carotid arteries, peripheral blood vessels, pediatric and adult congenital and structural heart conditions, and valve replacements. The clarity, consistency and quality of these procedure reports will be a marked improvement over current approaches, which are inconsistent and vary widely among catheterization labs and vendors.

“Getting everyone on the same page is crucial to improving care for the patient,” said Tim Sanborn, M.D., MS, FACC, FAHA, FSCAI, clinical professor of medicine, University of Chicago Pritzker School of Medicine, and project chair. “Structured reporting increases the efficiency and effectiveness of the entire catheterization team, improves communication and coordination of care, and reduces delays in care. In addition, it facilitates the use of data for clinical care, quality assessment, performance improvement, billing, regulatory and other purposes.”

The new published statement offers specific report templates to illustrate the principles of structured reporting. These templates help users manage the patient’s data before, during and after the procedure and integrate data management into the workflows of all care team members. They provide a step-by-step process from scheduling to analysis and outline how to compile a report once the procedure is complete. They also identify when, where and how the processes of data are integrated into the workflow.

“These data-intense reports will efficiently convey the details of the procedure, findings, analyses and recommendations of care for the patient,” said James E. Tcheng, M.D., FACC, FSCAI, FESC, interventional cardiologist, director of Duke Information Systems for cardiovascular care, Duke University Health System, Durham, N.C., and vice chair of the project. “They will reduce the documentation burden and allow physicians to focus more on care recommendations for the patient.”

Widespread adoption of this structured reporting approach will require a substantial transformation of catheterization laboratory reporting that will affect administration, physicians and staff. This transformation, however, is aligned with federal initiatives promoting the universal adoption of electronic health records (EHRs).

In providing report templates, the joint effort will help accelerate the development and application of this new approach to reporting catheterization procedures. Yet also critical to the success of this effort is for health information technology vendors to build and implement systems that enable structured reporting.

For more information: www.cardiosource.org, www.americanheart.org, www.scai.org, www.hl7.org, www.ihe.net, www.sts.org and www.vascularweb.org

Related Content

First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Arterial Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER
News | Cath Lab| July 07, 2017
Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Heartflow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

HeartFlow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

Technology | CT Angiography (CTA)| July 06, 2017
July 6, 2017 — GE Healthcare and HeartFlow Inc.
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Edwards Sapien 3 cleared by FDA to use for valve in valve mitral procedures

One of the top stories for the month was the Edwards Sapien 3 TAVR valve gaining FDA clearance for use in transcatheter valve-in-valve aortic and mitral procedures. 

Feature | June 30, 2017
June 30, 2017 — Here is the list of the most popular pieces of content on the Diagnostic and Interventional Cardiolog
Overlay Init